Blood concentrations of endothelin, interleukins 6 and 10 in men with diabetes mellitus

Main Article Content

E.V. Luchytskiy
V.E. Luchytskiy
G.A. Zubkova
V.M. Rybalchenko
I.I. Skladanna

Abstract

Background. Pathological activation of cytokines is one of the key links in the pathogenesis of diabetes mellitus (DM) and the development of its complications, in particular from the cardiovascular system. According to the vast majority of researchers, the imbalance of pro- and anti-inflammatory cytokines in patients with diabetes mellitus is a significant risk factor for mortality from cardiovascular disease. The purpose of the study was to determine the concentration of markers of a nonspecific inflammatory response (interleukin (IL) 6 and IL-10) in the blood of men with DM and their association with glycated hemoglobin levels and body mass index. Materials and methods. There were examined 46 men with type 2 DM and 28 men with type 1 DM. According to the results of the analysis of variance of the control group, type 2 DM and type 1 DM had significant differences in some indicators. Results. The correlation analysis of the obtained indicators of interleukin concentration showed that in men with type 2 DM under the age of 50 years, the indicators of IL-6 concentration significantly positively correlated with indicators of IL-10 concentration in blood (Spearman’s correlation coefficient 0.562, p < 0.031) and negatively with the duration of diabetes mellitus (Spearman’s correlation coefficient –0.508, p < 0.031). In the group of patients with type 2 DM aged 50 years and older, there was a positive correlation between the blood concentration of IL-6 with the blood concentration of IL-10 (Spearman’s correlation coefficient 0.509, p < 0.031), the blood concentration of IL-10 with glycated hemoglobin levels (Spearman’s correlation coefficient 0.391, p < 0.04) and the duration of diabetes mellitus (Spearman’s correlation coefficient 0.551, p < 0.005). In the group of patients with type 1 DM, there was a positive correlation of IL-6 in the blood with indicators of the blood concentration of IL-10 (Spearman’s correlation coefficient 0.707, p < 0.001) and a positive correlation between the concentration of IL-10 with the duration of DM (Spearman’s correlation coefficient 0.379, p < 0.039). Conclusions. Mean levels of IL-6 were significantly elevated in men with type 2 diabetes aged 50 years and older. Mean IL-10 levels were significantly elevated in men with type 2 diabetes regardless of the age of the patients. A significant positive correlation was found between the indicators of IL-6 and IL-10 in the examined patients with type 2 diabetes regardless of age also in patients with type 1 diabetes mellitus.

Article Details

How to Cite
Luchytskiy, E., V. Luchytskiy, G. Zubkova, V. Rybalchenko, and I. Skladanna. “Blood Concentrations of Endothelin, Interleukins 6 and 10 in Men With Diabetes Mellitus”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 17, no. 4, Sept. 2021, pp. 280-6, doi:10.22141/2224-0721.17.4.2021.237340.
Section
Original Researches

References

Hameed I, Masoodi SR, Mir SA, Nabi M, Ghazanfar K, Ganai BA. Type 2 diabetes mellitus: From a metabolic disorder to an inflammatory condition. World J Diabetes. 2015 May 15;6(4):598-612. doi: 10.4239/wjd.v6.i4.598.

Gorshkov IP, Zoloedov VI. The adipokines role in pathogenesis of the 2nd type diabetes mellitus and metabolic syndrome (review). Vestnik novyh medicinskih tehnologij.  2010;12(1):132-134. (in Russian).

Zak KP, Tronko ND, Popova VV, Butenko AK. Diabetes, Immunity, Cytokines. Kyiv: Kniga-plyus; 2015. 485 p. (in Russian).

Zhuravlyova LV, Sokolnikova NV. Interaction of adipokines and proinflammatory interleukins in patients with type 2 diabetes mellitus. Mìžnarodnij endokrinologìčnij žurnal. 2012;(45):13-17. (in Ukrainian).

Gerber Y, Tanne D, Medalie JH, Goldbourt U. Serum uric acid and long-term mortality from stroke, coronary heart disease and all causes. Eur J Cardiovasc Prev Rehabil. 2006 Apr;13(2):193-8. doi: 10.1097/01.hjr.0000192745.26973.00.

Gozhenko AI, Kuznetsova AS, Kuznetsova YeS, Byts' TN, Susla AB. Endothelial dysfunction in the pathogenesis of complications of diabetes mellitus. Message 1. Endothelial dysfunction: etiology, pathogenesis, and diagnostic methods. Endocrynologia. 2017; 22(2):171-81.

Peng Z, Sun Y, Lv X, Zhang H, Liu C, Dai S. Interleukin-6 Levels in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. PLoS One. 2016 Feb 5;11(2):e0148531. doi: 10.1371/journal.pone.0148531.

Dutheil F, Gordon BA, Naughton G, et al. Cardiovascular risk of adipokines: a review. J Int Med Res. 2018 Jun;46(6):2082-2095. doi: 10.1177/0300060517706578.

Maggio M, Lauretani F, Ceda GP, et al. Association between hormones and metabolic syndrome in older Italian men. J Am Geriatr Soc. 2006 Dec;54(12):1832-8. doi: 10.1111/j.1532-5415.2006.00963.x.

Marques-Vidal P, Bastardot F, von Känel R, et al. Association between circulating cytokine levels, diabetes and insulin resistance in a population-based sample (CoLaus study). Clin Endocrinol (Oxf). 2013 Feb;78(2):232-41. doi: 10.1111/j.1365-2265.2012.04384.x.

Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 2002 Apr;51(4):1131-7. doi: 10.2337/diabetes.51.4.1131.

Top C, Uslu SA, Onde ME. The relationship between body surface area and insulin resistance, serum IL-6 levels in patients with type 2 diabetes. Diabetes. 2009;58(Suppl 1):167-168.

Aroor AR, McKarns S, Demarco VG, Jia G, Sowers JR. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism. 2013 Nov;62(11):1543-52. doi: 10.1016/j.metabol.2013.07.001.

Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683-765. doi: 10.1146/annurev.immunol.19.1.683.

McDade TW, Tallman PS, Adair LS, Borja J, Kuzawa CW. Comparative insights into the regulation of inflammation: levels and predictors of interleukin 6 and interleukin 10 in young adults in the Philippines. Am J Phys Anthropol. 2011 Nov;146(3):373-84. doi: 10.1002/ajpa.21586.

Tsoi LG, Zalova TB, Satieva NS, Rysmatova FT, Polupanov AG, Sabirov IS. Association of cytokine hemodynamic and metabolic factors in individuals at high risk of cardiovascular complications. Vestnik KRSU. 2017;17(7):76-79. (in Russian).

Al-Shukaili A, Al-Ghafri S, Al-Marhoobi S, Al-Abri S, Al-Lawati J, Al-Maskari M. Analysis of inflammatory mediators in type 2 diabetes patients. Int J Endocrinol. 2013;2013:976810. doi: 10.1155/2013/976810.

Choi KM, Ryu OH, Lee KW, et al. Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res Clin Pract. 2007 Feb;75(2):235-40. doi: 10.1016/j.diabres.2006.06.019.

Hansen D, Dendale P, Beelen M, et al. Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients. Eur J Appl Physiol. 2010 Jun;109(3):397-404. doi: 10.1007/s00421-010-1362-5.

Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond). 2013 Feb;124(3):139-52. doi: 10.1042/CS20120198.

Alexandraki K, Piperi C, Kalofoutis C, Singh J, Alaveras A, Kalofoutis A. Inflammatory process in type 2 diabetes: The role of cytokines. Ann N Y Acad Sci. 2006 Nov;1084:89-117. doi: 10.1196/annals.1372.039.

Serik SA, Chenchik TA, Serdobinskaya-Kanivets EN, Bondar TN. Interleukin-10 and pro / anti-inflammatory cytokine balance in heart failure in patients with type 2 diabetes mellitus. Ukraïnsʹskij terapevtičeskij žurnal. 2012;(3-4):58-63.

Aroor AR, McKarns S, Demarco VG, Jia G, Sowers JR. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism. 2013 Nov;62(11):1543-52. doi: 10.1016/j.metabol.2013.07.001.

van Exel E, Gussekloo J, de Craen AJ, Frölich M, Bootsma-Van Der Wiel A, Westendorp RG; Leiden 85 Plus Study. Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study. Diabetes. 2002 Apr;51(4):1088-92. doi: 10.2337/diabetes.51.4.1088.

Saraiva M, O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010 Mar;10(3):170-81. doi: 10.1038/nri2711.

Randeria SN, Thomson GJA, Nell TA, Roberts T, Pretorius E. Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation. Cardiovasc Diabetol. 2019 Jun 4;18(1):72. doi: 10.1186/s12933-019-0870-9.

Welsh P, Murray HM, Ford I, Trompet S, de Craen AJ, Jukema JW, et al. Circulating interleukin-10 and risk of cardiovascular events: a prospective study in the elderly at risk. Arterioscler Thromb Vasc Biol. 2011 Oct;31(10):2338-44. doi: 10.1161/ATVBAHA.111. 231795. 

Botha-Scheepers S, Watt I, Slagboom E, de Craen AJ, Meulenbelt I, Rosendaal FR, et al. Innate production of tumour necrosis factor alpha and interleukin 10 is associated with radiological progression of knee osteoarthritis. Ann Rheum Dis. 2008 Aug;67(8):1165-9. doi: 10.1136/ard.2007.084657. 

Rodrigues KF, Pietrani NT, Bosco AA, Campos FMF, Sandrim VC, Gomes KB. IL-6, TNF-α, and IL-10 levels/polymorphisms and their association with type 2 diabetes mellitus and obesity in Brazilian individuals. Arch Endocrinol Metab. 2017 Sept-Oct;61(5):438-446. doi: 10.1590/2359-3997000000254.